FindTrial
Sign In

Parathyroid glands are differentiated from lymph node by carbon particles in surgery of thyroid carcinoma. A randomised prospective control trial

The role of Carbon Nanoparticles in identifying lymph nodes and preserving parathyroid in total endoscopic surgery of thyroid carcinoma.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14005042
Enrollment
Unknown
Registered
2014-07-27
Start date
2013-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid carcinoma

Interventions

1:injection carbon particles
2:not injection carbon particles

Sponsors

Changzheng Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patient who want to perform endoscopic surgery (women or men); 2. Age from 18y to 70y; 3. Patient who was diagnosed as thyroid carcinoma by FNA before surgery; 4. The largest diameter of mass not more than 4cm; 5. Agree to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant; mental disease; failure of heart, lung, brain, renal, coagulation system; 2. History of radiotherapy in neck; 3. The diameter of mass more than 4cm; 4. Concomitant with Grave's disease; 5. Enlarged level VI lymph node was found by ultrasound, CT or puncture biopsy.

Design outcomes

Primary

MeasureTime frame
number of parathyroid in pathological specimens;postoperative calcium;postoperative PTH;number of lymph node in pathological specimens;number of metastatic lymph node in pathological specimens;—

Countries

China

Contacts

Public ContactWangbin
wangbin12048@163.com+86 13774200583

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 18, 2026